BEST OF ONCOLOGY WEST 2024: Colorectal GI Cancer – Dr. Sharlene Gill
OR
Chair
Dr. Sharlene Gill
Dr. Daniel Heng
Panelist
Dr. Sharlene Gill
Studies/trials discussed:
- Prospect Trial
- Leap 017 ph3 Lenvatinib+Pembrolizumab vs rego
- Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer (Sunlight Study)
- Her 2 Targeted therapies in patients with advanced or metastatic colorectal cancer
- Desiny CRC02 Study Design
- Mountaineer 003 Study Design
- LBA10 Sotorasib plus panitumumab versus standard-of-care for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC): CodeBreak 300 phase III study
- Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
